Health

The PolG Foundation awards over $3.5M in academic grants to pioneer POLG research

The PolG Foundation is a nascent foundation established in 2022 by a PolG family, with the mission to support and accelerate research to find effective treatments and a cure for PolG mitochondrial disorders.  To view the Multimedia News Release, please click: https://www.multivu.com/players/English/9224051-polg-foundation-awards-academic-grants-pioneer-polg-research/ With both a dedicated and experienced Board of Directors and Scientific…

thaipr.net

16 พ.ย. 66

More than two in three people with diabetes already have complications at diagnosis, International Diabetes Federation study finds

Global research from the International Diabetes Federation reveals that 72% of people living with diabetes only received their diagnosis because they had at least one of the related complications – such as loss of vision, nerve damage or heart disease. Seven in ten people living with diabetes (72%) only found out they had diabetes after […]

thaipr.net

15 พ.ย. 66

Illumina launches Global Health Access Initiative to support acceleration of pathogen sequencing in low- and middle-income countries

Program aims to address key barriers to genomic sequencing in-country Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the launch of the Global Health Access Initiative to support access to pathogen sequencing tools for public health in low- and middle-income countries (LMICs). The program, developed with guidance from […]

thaipr.net

14 พ.ย. 66

Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer

The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and SciClone Pharmaceuticals (Holdings) Ltd. (“SciClone”), an international biopharmaceutical company, today announced that they have entered into an exclusive sub-licensing agreement to develop and commercialize ORSERDU® (elacestrant) in the People’s Republic of China (China), in an effort to expand treatment options…

thaipr.net

9 พ.ย. 66
1 … 21 22 23 24 25 … 128

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.